Latest abatacept clinical trial results
A second clinical trial of abatacept has failed to demonstrate improved outcomes in patients with lupus nephritis.
The trial results published in the journal Arthritis & Rheumatology show no benefit from a 24-week course added to a regimen of cyclophosphamide followed by azathioprine.
The researchers enrolled 134 patients in the randomized, double-blind phase II add-on trial. Patients received either abatacept or placebo in